Back to Rankings

TVGN

Tevogen BioD
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-11
View Chart
+
Peers tracked
11
U.S. public peers
Grade Position
In line
vs peer average
TVGN vs peer average
51/100
TVGN vs. peer average (D vs. D)
Grade spread
A 1 · B 2 · F 8
Graded peers loaded
Coverage
11 graded
100% of tracked

Peer overview

ATYR is the first available peer comparator.

Clinical-stage biotech of similar scale; shows how partnership/licensing news can re-rate small-cap biotechs.

Peer source comes from the stored AI memo or peer model
Grades and factor rows use RankAlpha API data when available
Missing peer scores remain blank instead of being estimated
Side-by-side comparison keeps the data contract visible
Top peerATYRaTyr
TVGN
Tevogen Bio
ATYR
aTyr
Grade
D
F
Momentum
86
8
Value
42
58
Sentiment
0
-
Setup Bias
Net Neutral
-
Market Cap
-
-
Posture
Defensive
Defensive

Grade position vs ATYR

TVGN / ATYR
Grade Position
In line
TVGN vs. peer average (D vs. D)
51/100
Momentum
86
TVGN
Value
42
ATYR
Sentiment
0
-

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs TVGN
1
ATYR
ATYR
F
20/100
+1
2
ACRV
ACRV
A
100/100
-3
3
NRXP
NRXP
B
80/100
-2
4
MREO
Mereo BioPharma Group plc ADR
B
80/100
-2
5
ESLA
Estrella Immunopharma Inc Common
F
20/100
+1
ATYR is the first peer returned for this comparison set.